Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT201211195280N10Phase 3Completed
Phase 3, single-arm trial of rivastigmine in post-traumatic stress disorder (PTSD), sponsored by Mashhad University of Medical Sciences. Started Aug 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT201211195280N10.